Payden & Rygel Has $14.36 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Payden & Rygel increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 519.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 28,380 shares of the healthcare conglomerate's stock after acquiring an additional 23,800 shares during the period. Payden & Rygel's holdings in UnitedHealth Group were worth $14,356,000 as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $30,000. Promus Capital LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $32,000. Pillar Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $40,000. Finally, DecisionPoint Financial LLC raised its stake in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after purchasing an additional 62 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 2.9 %

NYSE:UNH traded down $15.50 during mid-day trading on Friday, hitting $524.94. The company had a trading volume of 9,914,705 shares, compared to its average volume of 4,256,040. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $480.17 billion, a P/E ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.61. The business's fifty day moving average is $509.24 and its two-hundred day moving average is $541.85. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm earned $5.83 earnings per share. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Finally, Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.